DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 33 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,184 | -40.3% | 4,335 | 0.0% | 0.00% | – |
| Q2 2023 | $18,727 | +182.3% | 4,335 | 0.0% | 0.00% | – |
| Q1 2023 | $6,633 | -3.2% | 4,335 | 0.0% | 0.00% | – |
| Q4 2022 | $6,850 | +37.0% | 4,335 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 4,335 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 4,335 | 0.0% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 4,335 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -5.9% | 4,335 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | -10.5% | 4,335 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -52.5% | 4,335 | 0.0% | 0.00% | – |
| Q1 2021 | $40,000 | -9.1% | 4,335 | 0.0% | 0.00% | – |
| Q4 2020 | $44,000 | +144.4% | 4,335 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | – | 4,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |